Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Biotech Investors Rush for the Exits After FDA Official Resigns: Heard on the Street
In This Article:
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and championed accelerated drug approvals, announced he was stepping down, citing irreconcilable differences with Health and Human Services Secretary Robert F. Kennedy Jr.
Terms and Privacy Policy